Clinical Trial Update: Vibegron for ENergy Thinking and Resilience in Aging [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating vibegron for energy, thinking, and resilience in aging in participants with obesity is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Vibegron (vibegron)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Obesity | Phase 3 | Status: NOT_YET_RECRUITING